Related Experiment Video
Updated: Jul 18, 2026
09:03
The Perinatal Asphyxiated Lamb Model: A Model for Newborn Resuscitation
Published on: August 15, 2018
[Perinatology for the pediatrician]
J-L Micheli1, S Gerber, M Roth-Kleiner
1Division de néonatologie, Département médico-chirurgical de pédiatrie, CHUV, 1011 Lausanne. Jean.Micheli@chuv.ch
Revue Medicale Suisse
|November 23, 2006
Summary
New perinatology knowledge aids in identifying high-risk pregnancies and reducing newborn complications. However, it has not decreased preterm delivery rates, highlighting areas for future research in neonatal care.
Area of Science:
- Neonatal Medicine
- Perinatal Health
- Pediatric Care
Context:
- Advances in perinatology have significantly improved outcomes for high-risk pregnancies and newborns.
- Despite progress, the incidence of preterm deliveries remains a persistent challenge in perinatal medicine.
Purpose:
- To review advancements in perinatology from a pediatrician's perspective.
- To discuss the impact of new knowledge on high-risk pregnancies, perinatal mortality, and newborn handicaps.
- To highlight areas where progress has been limited, such as preterm delivery rates.
Summary:
- New perinatology knowledge facilitates the identification of high-risk pregnancies and has led to decreased perinatal mortality and major handicaps in high-risk newborns.
- Current advancements have not resulted in a reduction in the rate of preterm deliveries.
- The discussion includes antenatal and intrapartum fetal assessment, as well as postnatal newborn evaluation, supported by practical data.
Impact:
- Provides pediatricians with updated knowledge on managing high-risk pregnancies and newborns.
- Identifies critical areas for further research and intervention to address preterm birth.
- Offers practical data and insights for everyday clinical concerns in perinatal and neonatal care.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...